| Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia K Xue, JK Jolly, AR Barnard, A Rudenko, AP Salvetti, MI Patrício, ... Nature medicine 24 (10), 1507-1512, 2018 | 176 | 2018 |
| Anti-VEGF therapy and the retina: an update V Tah, HO Orlans, J Hyer, E Casswell, N Din, V Sri Shanmuganathan, ... Journal of ophthalmology 2015, 2015 | 141 | 2015 |
| In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review HO Orlans, SJ Hornby, I Bowler Eye 25 (4), 489-493, 2011 | 126 | 2011 |
| Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-driven transduction of mouse and human retina MI Patrício, AR Barnard, HO Orlans, ME McClements, RE MacLaren Molecular Therapy-Nucleic Acids 6, 198-208, 2017 | 65 | 2017 |
| Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK A Gupta, HO Orlans, SJ Hornby, I Bowler Graefe's Archive for Clinical and Experimental Ophthalmology 252, 1825-1830, 2014 | 54 | 2014 |
| Human retinal explant culture for ex vivo validation of AAV gene therapy HO Orlans, TL Edwards, SR De Silva, MI Patrício, RE MacLaren Retinal Gene Therapy: Methods and Protocols, 289-303, 2018 | 26 | 2018 |
| Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study P Corazza, FM D’Alterio, J Kabbani, MMR Alam, S Mercuri, HO Orlans, ... BMC ophthalmology 21, 1-8, 2021 | 22 | 2021 |
| Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa HO Orlans, ME McClements, AR Barnard, ... Nature Communications 12 (1), 4934, 2021 | 20 | 2021 |
| Effect of AAV-mediated rhodopsin gene augmentation on retinal degeneration caused by the dominant P23H rhodopsin mutation in a knock-in murine model HO Orlans, AR Barnard, MI Patrício, ME McClements, RE MacLaren Human Gene Therapy 31 (13-14), 730-742, 2020 | 16 | 2020 |
| Filtration of short-wavelength light provides therapeutic benefit in retinitis pigmentosa caused by a common rhodopsin mutation HO Orlans, J Merrill, AR Barnard, PC Issa, SN Peirson, RE MacLaren Investigative Ophthalmology & Visual Science 60 (7), 2733-2742, 2019 | 16 | 2019 |
| Secretory cells of the supraoptic nucleus have central as well as neurohypophysial projections AN Inyushkin, HO Orlans, REJ Dyball Journal of Anatomy 215 (4), 425-434, 2009 | 15 | 2009 |
| Impact of vital dyes on cell viability and transduction efficiency of AAV vectors used in retinal gene therapy surgery: an in vitro and in vivo analysis AP Salvetti, MI Patrício, AR Barnard, HO Orlans, DG Hickey, RE MacLaren Translational vision science & technology 6 (4), 4-4, 2017 | 10 | 2017 |
| Direct ophthalmoscopy should be taught within the context of its limitations HO Orlans Eye 30 (2), 326-327, 2016 | 9 | 2016 |
| Vascular density and retinal function in patients with retinitis pigmentosa evaluated by swept-source OCT angiography and microperimetry P Corazza, P Cirafici, V Testa, HO Orlans, M Berisso, CE Traverso, ... Ophthalmologica 244 (1), 27-33, 2021 | 8 | 2021 |
| A novel achromatopsia mouse model resulting from a naturally occurring missense change in Cngb3 MM Hassall, AR Barnard, HO Orlans, ME McClements, PC Issa, SA Aslam, ... Investigative Ophthalmology & Visual Science 59 (15), 6102-6110, 2018 | 6 | 2018 |
| Osmotic modulation of stimulus‐evoked responses in the rat supraoptic nucleus GS Bhumbra, HO Orlans, REJ Dyball European Journal of Neuroscience 27 (8), 1989-1998, 2008 | 6 | 2008 |
| Using QR smartphone technology to improve patient communication and information distribution A Azad, DAH Laidlaw, HO Orlans Eye 36 (6), 1321-1322, 2022 | 5 | 2022 |
| Slowly progressive retinitis pigmentosa caused by two novel mutations in the MAK gene JM Gray, HO Orlans, M Shanks, P Clouston, RE MacLaren Ophthalmic Genetics 39 (4), 508-511, 2018 | 4 | 2018 |
| Dynamic in vivo quantification of rod photoreceptor degeneration using fluorescent reporter mouse models of retinitis pigmentosa HO Orlans, AR Barnard, RE MacLaren Experimental eye research 190, 107895, 2020 | 3 | 2020 |
| Comment on:‘Sector retinitis pigmentosa caused by mutations of the RHO gene’ HO Orlans, RE MacLaren Eye 34 (8), 1477-1478, 2020 | 2 | 2020 |
